October 31, 2022 Experience Emerson $14 billion sale of Climate Technologies to Blackstone We are advising Emerson on the transaction
October 17, 2022 Experience European Biotech Acquisition $200 million combination with Oculis We are advising European Biotech Acquisition Corp. on its deSPAC transaction
September 29, 2022 Experience NewMed Energy proposed combination with Capricorn Energy We are advising NewMed on the transaction
September 20, 2022 Experience Pon sale of interest in Hiller to Littlejohn & Co. We advised Pon on the transaction
September 8, 2022 Experience Tencent €300 million investment in Ubisoft We are advising Tencent on the transaction
August 4, 2022 Experience Gilead Sciences $405 million acquisition of MiroBio We are advising Gilead Sciences on the transaction
August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
July 20, 2022 Experience Pon sale of its flow control businesses to MiddleGround Capital We advised Pon on the transaction